Serhan Alkan
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 2%
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 33
-
- Ubiquitin and proteasome pathways 8
- Protein Degradation and Inhibitors 7
- Histone Deacetylase Inhibitors Research 7
- Co-authors
- Eric D. Hsi (14 shared papers)Keith F. Izban (14 shared papers)Hesham M. Amin (10 shared papers)Melek Ergin (9 shared papers)Kevin Barton (6 shared papers)Bertram Schnitzer (7 shared papers)Mitchell F. Denning (4 shared papers)Jan M. Orenstein (2 shared papers)
- Journals
- American Journal of Clinical Pathology (9 papers)Blood (8 papers)Leukemia Research (7 papers)Archives of Pathology & Laboratory Medicine (7 papers)British Journal of Haematology (6 papers)
- Partner nations
- United StatesChinaTürkiye
In The Last Decade
Serhan Alkan
107 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 108
- Pathology and Forensic Medicine 826
- Oncology 1.2k
- Hematology 483
- Genetics 373
- Immunology 426
Countries citing papers authored by Serhan Alkan
This map shows the geographic impact of Serhan Alkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serhan Alkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serhan Alkan more than expected).
Fields of papers citing papers by Serhan Alkan
This network shows the impact of papers produced by Serhan Alkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serhan Alkan. The network helps show where Serhan Alkan may publish in the future.
Co-authors
The 25 scholars most cited alongside Serhan Alkan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 220 | |
| 2 | 2003 | 173 | |
| 3 | 2002 | 172 | |
| 4 | 1997 | 172 | |
| 5 | 2004 | 135 | |
| 6 | 2001 | 135 | |
| 7 | 2013 | 126 | |
| 8 | 2013 | 103 | |
| 9 | 2004 | 96 | |
| 10 | 2001 | 84 | |
| 11 | 2004 | 84 | |
| 12 | 2001 | 81 | |
| 13 | 2016 | 79 | |
| 14 | 2002 | 78 | |
| 15 | 1999 | 70 | |
| 16 | 2016 | 69 | |
| 17 | 1999 | 64 | |
| 18 | 2009 | 63 | |
| 19 | 2000 | 61 | |
| 20 | 1997 | 60 |
About Serhan Alkan
Serhan Alkan is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Oncology, Hematology and Genetics, having authored 108 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (33 papers), Viral-associated cancers and disorders (24 papers), Chronic Lymphocytic Leukemia Research (14 papers), Acute Myeloid Leukemia Research (11 papers), Ubiquitin and proteasome pathways (8 papers), Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (7 papers) and Parvovirus B19 Infection Studies (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (826 citations), Oncology (1.2k citations), Hematology (483 citations), Genetics (373 citations) and Immunology (426 citations). Serhan Alkan has collaborated with scholars based in United States, China and Türkiye. Frequent co-authors include Eric D. Hsi, Keith F. Izban, Hesham M. Amin, Melek Ergin, Kevin Barton, Bertram Schnitzer, Mitchell F. Denning, Jan M. Orenstein, Hongyu Ni and Yu Wang. Their work appears in journals such as American Journal of Clinical Pathology, Blood, Leukemia Research, Archives of Pathology & Laboratory Medicine and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.